Shanghai, China

Bo Qiu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Cinkate Pharm Tech (Shanghai) Co., Ltd., Cinkate Pharmaceutical Intermediates Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Qiu. Retrieved from https://idiyas.com/inventor/bo-qiu-0aixj28b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bo Qiu: Innovator in Pharmaceutical Development

Introduction

Bo Qiu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on triptolide derivatives. His research focuses on enhancing the efficacy and safety of these compounds, which have promising applications in immunosuppression and anti-tumor therapies.

Latest Patents

Bo Qiu holds a patent for a triptolide derivative and its preparation method. The patent describes a triptolide derivative that exhibits improved immunosuppressive activity and anti-tumor activity, while also demonstrating low toxicity and high safety. This advancement presents excellent development and application prospects in the pharmaceutical industry.

Career Highlights

Throughout his career, Bo Qiu has worked with Cinkate Pharmaceutical Intermediates Co., Ltd. and Cinkate Pharm Tech (Shanghai) Co., Ltd. His experience in these companies has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Bo Qiu has collaborated with notable colleagues, including Fei Xiao and Peng Zhang. These partnerships have contributed to his research and development efforts in the pharmaceutical sector.

Conclusion

Bo Qiu is a distinguished inventor whose work on triptolide derivatives has the potential to significantly impact the pharmaceutical industry. His innovative approach and dedication to improving drug safety and efficacy are commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…